STEK — Stemtech Corporation

Opening the full analysis uses 1 of your 3 free tickers today.

Open full analysis

Chart, dilution, float and news for STEK in the TickerWise workspace.

Stemtech Corporation, a stem cell nutrition company, develops science-based products to help the body maintain healthy stem cell physiology in the Americas, Latin America, and Asia. The company's products enhance and support the work of the body's stem cells by releasing more stem cells, helping to circulate them in the blood, and migrate them into tissues, where they can perform their daily function of renewal for optimal health. It offers its dietary supplement products under the RCM System, stemrelease3, Stemflo MigraStem, DermaStem, DermaStem Lift, OraStem, and D-Fuze brands. The company is based in Miramar, Florida.

Company profile

• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic
• Country: US
• Exchange: Other OTC
• Employees: 1
• Website: https://www.stemtech.com

Latest SEC filings for STEK

• 2026-05-2910-K
• 2026-05-14NT 10-Q/A
• 2026-05-14NT 10-Q
• 2026-03-31NT 10-K
• 2025-11-1910-Q
• 2025-11-14NT 10-Q
• 2025-08-1910-Q
• 2025-08-14NT 10-Q
• 2025-07-1710-Q
• 2025-06-3010-K

Opening the full analysis uses 1 of your 3 free tickers today.

Open full analysis

Educational tool only — not investment advice.